Fabtech Cleanrooms June 2026 orders at 33.79 crore; order book 362.41 crore

Business Updates View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.3%Reaction day

₹400.95

prior close

₹404.50

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.0%+3.3% vs market

Industrial Products peers, median of 132sector-0.8%+3.1% vs sector

On the reaction day the stock moved 3.3 pts more than Nifty Microcap 250 and 3.1 pts more than its Industrial Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

+1.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.3-1.0+3.3-0.8+3.1

Next day

+1.0-0.4+1.4-0.3+1.3

-4.0-0.8-3.2-0.6-3.3

-8.7-1.9-6.8-1.8-6.9

-5.0-1.3-3.7-1.8-3.2

-5.2-1.0-4.2-1.6-3.6

-3.7-2.8-0.9-2.5-1.3

15d

-2.4+0.4-2.7-3.4+1.1

+2.1+2.4-0.3-3.2+5.3

+13.3+1.0+12.3-3.6+16.9

+24.7+1.8+23.0-3.2+27.9

UpDownMarket · Nifty Microcap 250Sector · Industrial Products peers, median of 132Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

This is a revised monthly business update from Fabtech Cleanrooms Limited for June 2026. The company secured consolidated orders of about 33.79 crore during the month, led by Pharma at 20.36 crore. HVAC Systems contributed 17.81 crore and Cleanroom Partitions 15.98 crore. Consolidated order book as of 30 June 2026 stands at 362.41 crore, with Renewable Energy (177.63 crore) and Pharma (147.40 crore) as top segments. Orders under active consideration total 514.78 crore.

Likely market impact

Steady monthly order inflows plus a pipeline of about 515 crore under consideration point to healthy revenue visibility and continued business momentum for shareholders.